SCHEMBL5024795

SCHEMBL5024795

NC(Cc1ccc(NCCO)cc1O)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.53
▸ USP2 O75604 3/20 0.53
▸ ALOX15 P16050 3/20 0.53
▸ HSD17B10 Q99714 3/20 0.53
▸ HIF1A Q16665 3/20 0.53
▸ LMNA P02545 3/20 0.53
▸ MAPT P10636 3/20 0.53
▸ BLM P54132 3/20 0.53
▸ PMP22 Q01453 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ RECQL P46063 2/20 0.53
▸ TDP1 Q9NUW8 2/20 0.53
▸ CYP3A4 P08684 2/20 0.53
▸ NFKB1 P19838 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ PKM P14618 2/20 0.53
▸ RGS12 O14924 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5024792 0.88 CYP3A4 (0.51) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL5024800 0.79 USP2 (0.54) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL5025015 0.78 SLC7A5 (0.57) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL1070680 0.78 SLC7A5 (0.57) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL4140820 0.76 KDM4E (0.66) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL2679928 0.76 KDM4E (0.66) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL3263898 0.76 ALDH1A1 (0.41) KDM4EUSP2LMNAMAPTBLM
SCHEMBL5025014 0.75 CYP3A4 (0.53) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL2028058 0.73 KDM4E (0.62) KDM4EUSP2ALOX15HSD17B10HIF1A
SCHEMBL2028640 0.73 KDM4E (0.62) KDM4EUSP2ALOX15HSD17B10HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012058325-A1 COMPOUNDS AND METHODS USEFUL FOR TREATMENT OF DISEASES MEDIATED BY HIF-1 ONCOTHYREON INC. (US) 2012-05-03 — — WO disclosed
WO-2011057220-A2 COMPOSITIONS AND METHODS FOR TREATING LYMPHOMA NORTHWESTERN UNIVERSITY (US) 2011-05-12 — — WO disclosed
Send feedback